Hepatic Leptin Action and Leptin Resistance
Hepatic Leptin Action and Leptin Resistance
批准号:
7142795
负责人:
ROBERT M O'DOHERTY
金额:
$28.96万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-08-01 至 2010-06-30
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The actions of the adipocyte-derived hormone leptin on lipid metabolism are proposed to be important in preventing the development of tissue lipotoxicity and lipid-related insulin resistance. This is best illustrated in leptin-deficient states, where the administration of exogenous leptin corrects systemic dyslipidemia, excessive storage of lipid in peripheral tissues such as the liver, and insulin resistance associated with this condition. Furthermore, states of leptin resistance such as human obesity and diet-induced obesity (DIO) are characterized by a similar metabolic phenotype to leptin deficient conditions, implicating a role for a loss of leptin action in the pathogenesis of the metabolic abnormalities of obesity. However, despite some progress, our understanding of the mechanisms of leptin regulation of lipid metabolism and insulin action, and the mechanisms of leptin resistance remains poor. Our recent work has focused on the effects and mechanisms of leptin action on lipid metabolism .in liver, a central organ in the regulation of whole-body lipid homeostasis. In brief these studies established a novel role for leptin in the acute regulation of hepatic lipid levels, an effect that is impaired in obesity, and identified a biochemical mechanism for this defect. Specifically, we have demonstrated (i) that leptin rapidly (within approximately 100 min) decreases liver triglyceride levels; (ii) that DIO induces resistance to the acute triglyceride-lowering effects of leptin; (iii) that activation of liver PI3-kinase is required for the effects of leptin on hepatic triglyceride levels, and (iv) that defective leptin activation of liver PI3-kinase is a novel mechanism of leptin resistance in obesity. The central objective of the current proposal is to extend these studies to determine (i) the lipid metabolic pathways in liver acutely regulated by leptin; (ii) the biochemical/molecular mechanisms of leptin action on hepatic lipid metabolism; (iii) the interactions of insulin and leptin on hepatic metabolism, and (iv) the biochemical mechanisms of hepatic leptin resistance in obesity. In undertaking these studies, we will increase our understanding of the mechanisms of leptin action and the contribution of leptin resistance to the metabolic abnormalities of obesity.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Dendritic Cells and Obesity
-
批准号:9107446
-
项目类别:
-
资助金额:$36.72万
-
财政年份:2015
-
负责人:ROBERT M O'DOHERTY
-
依托单位:
Dendritic Cells and Obesity
-
批准号:9293273
-
项目类别:
-
资助金额:$36.72万
-
财政年份:2015
-
负责人:ROBERT M O'DOHERTY
-
依托单位:
Hepatic Leptin Action and Leptin Resistance
-
批准号:8006711
-
项目类别:
-
资助金额:$3.65万
-
财政年份:2010
-
负责人:ROBERT M O'DOHERTY
-
依托单位:
Hepatic Leptin Action and Leptin Resistance
-
批准号:7265205
-
项目类别:
-
资助金额:$28.12万
-
财政年份:2006
-
负责人:ROBERT M O'DOHERTY
-
依托单位:
Leptin Action and Macrophages
-
批准号:8104928
-
项目类别:
-
资助金额:$44.63万
-
财政年份:2006
-
负责人:ROBERT M O'DOHERTY
-
依托单位:
Hepatic Leptin Action and Leptin Resistance
-
批准号:7457847
-
项目类别:
-
资助金额:$27.56万
-
财政年份:2006
-
负责人:ROBERT M O'DOHERTY
-
依托单位:
Hepatic Leptin Action and Leptin Resistance
-
批准号:7630409
-
项目类别:
-
资助金额:$27.56万
-
财政年份:2006
-
负责人:ROBERT M O'DOHERTY
-
依托单位:
Leptin Action and Macrophages
-
批准号:8236922
-
项目类别:
-
资助金额:$37.12万
-
财政年份:2006
-
负责人:ROBERT M O'DOHERTY
-
依托单位:
Leptin Action and Macrophages
-
批准号:8462594
-
项目类别:
-
资助金额:$35.82万
-
财政年份:2006
-
负责人:ROBERT M O'DOHERTY
-
依托单位:
Leptin Action and Macrophages
-
批准号:8663884
-
项目类别:
-
资助金额:$37.12万
-
财政年份:2006
-
负责人:ROBERT M O'DOHERTY
-
依托单位:
LEPTIN INDUCED REVERSAL ON INSULIN RESISTANCE IN OBESITY
-
批准号:6498204
-
项目类别:
-
资助金额:$21.87万
-
财政年份:2001
-
负责人:ROBERT M O'DOHERTY
-
依托单位:
Lipids, Inflammatory Pathways, and Insulin Resistance
-
批准号:7632218
-
项目类别:
-
资助金额:$26.85万
-
财政年份:2001
-
负责人:ROBERT M O'DOHERTY
-
依托单位:
Lipids Inflammatory Pathways and Insulin Resistance
-
批准号:7148938
-
项目类别:
-
资助金额:$27.52万
-
财政年份:2001
-
负责人:ROBERT M O'DOHERTY
-
依托单位:
Lipids, Inflammatory Pathways, and Insulin Resistance
-
批准号:7429760
-
项目类别:
-
资助金额:$26.89万
-
财政年份:2001
-
负责人:ROBERT M O'DOHERTY
-
依托单位:
LEPTIN INDUCED REVERSAL ON INSULIN RESISTANCE IN OBESITY
-
批准号:6256417
-
项目类别:
-
资助金额:$21.93万
-
财政年份:2001
-
负责人:ROBERT M O'DOHERTY
-
依托单位:
LEPTIN INDUCED REVERSAL ON INSULIN RESISTANCE IN OBESITY
-
批准号:6628600
-
项目类别:
-
资助金额:$21.78万
-
财政年份:2001
-
负责人:ROBERT M O'DOHERTY
-
依托单位:
Lipids, Inflammatory Pathways, and Insulin Resistance
-
批准号:7266224
-
项目类别:
-
资助金额:$27.48万
-
财政年份:2001
-
负责人:ROBERT M O'DOHERTY
-
依托单位:
LEPTIN INDUCED REVERSAL ON INSULIN RESISTANCE IN OBESITY
-
批准号:6703155
-
项目类别:
-
资助金额:$21.7万
-
财政年份:2001
-
负责人:ROBERT M O'DOHERTY
-
依托单位:
T32 Research Training in Diabetes and Endocrinology
-
批准号:10649498
-
项目类别:
-
资助金额:$34.22万
-
财政年份:1975
-
负责人:ROBERT M O'DOHERTY
-
依托单位:
Research Training in Diabetes and Endocrinology
-
批准号:10115902
-
项目类别:
-
资助金额:$3.26万
-
财政年份:1975
-
负责人:ROBERT M O'DOHERTY
-
依托单位:
国内基金
海外基金
登录
查看更多内容
KCTD10对2型免疫反应(Th2)的调控研究
-
批准号:2020JJ4441
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:任凯群
-
依托单位:
IL-6受体泛素化调控机制
-
批准号:32070775
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:李姝
-
依托单位:
乙烯合酶ACS家族的AEF蛋白调节拟南芥开花时间的机制研究
-
批准号:31970735
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2019
-
负责人:江静
-
依托单位:
USP13调控IL-18诱导的NF-κB活化的分子机制研究
-
批准号:31900556
-
项目类别:青年科学基金项目
-
资助金额:26.0万元
-
批准年份:2019
-
负责人:林恒
-
依托单位:
let-7通过SOCS1调控巨噬细胞极化及其在前列腺癌进展中的作用
-
批准号:81560465
-
项目类别:地区科学基金项目
-
资助金额:38.0万元
-
批准年份:2015
-
负责人:王志刚
-
依托单位:
纳米微粒载NF-κB圈套基因对神经发育缺陷大鼠模型的干预研究
-
批准号:30870892
-
项目类别:面上项目
-
资助金额:8.0万元
-
批准年份:2008
-
负责人:吕路线
-
依托单位: